Compare AbCellera Biologics Inc (ABCL) vs ADT Inc (ADT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs ADT Inc — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while ADT Inc trades at $7.39 (market cap $5.44B). The key difference: ADT Inc is the larger of the two by market cap, and ADT Inc pays a 2.95% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | ADT | |
|---|---|---|
Market Cap | $2.99B | $5.44B |
Sector | Health | Industrials |
52-Week High | $9.76 | $8.85 |
52-Week Low | $2.78 | $6.30 |
Enterprise Value | $2.58B | $13.13B |
Dividend Yield | — | 2.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About ADT Inc
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. ADT offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. It provides interactive home and business automation solutions designed to control access, react to movement, and sense carbon monoxide, flooding, changes in temperature or other environmental conditions, as well as address personal emergencies, such as injuries and medical emergencies. In addition, it offers professional monitoring of third-party devices through ADT Canopy platform. The product brands of the company are ADT and ADT Pulse, and Protection One brand.
Read more on ADT →
